DJIA 16,408.54 -16.31 -0.10%
NASDAQ 4,095.52 0.00 0.00%
S&P 500 1,864.85 2.54 0.14%
market minute promo

5.30 -0.08 (-1.49%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

OREX $5.30 -1.49%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.35
Previous Close $5.38
Daily Range $5.23 - $5.49
52-Week Range $4.60 - $7.84
Market Cap $591.2M
P/E Ratio -6.73
Dividend (Yield) $0.00 (0.0%)
Volume 1,385,817
Average Daily Volume 2,488,407
Current FY EPS -$0.07





Orexigen Therapeutics, Inc. (OREX) Description

A biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system, disorders, with an initial focus on obesity. Website:

News & Commentary Rss Feed

What Arena's Belviq Television Ad Campaign Means For The Stock

Is Orexigen Attractive Near 52-Week Lows?

Relative Strength Alert For Orexigen Therapeutics

OREX Makes Notable Cross Below Critical Moving Average

Narrower Loss at Orexigen in Q4 - Analyst Blog

Have Anti-Obesity Drug Companies Failed?

Arena Earnings On Tap

Orexigen Sees Positives In European Application For Contrave

Arena Pharmaceuticals, Inc. Earnings: What to Expect Thursday

Will the obesity-drug maker avoid its biggest competitor's fate?

Why SINA, VIVUS, and Tenet Healthcare Tumbled Today

Even as the stock market gave up a small amount of ground today, these stocks got hammered hard. Find out why here.

See More OREX News...

OREX's Top Competitors

OREX $5.30 (-1.49%)
Current stock: OREX
GILD $70.00 (1.04%)
Current stock: GILD
AMGN $115.46 (-0.07%)
Current stock: AMGN
BIIB $290.54 (-0.32%)
Current stock: BIIB